2024 (Volume 25 | 1 Issues)

Dec 24

Issue: 1/2024

2023 (Volume 24 | 1 Issues)

Dec 23

Issue: 1/2023

2022 (Volume 23 | 1 Issues)

Dec 22

Issue: 1/2022

2022 (Volume 22 | 2 Issues)

Feb 22

Issue: Special Issue 1/2022

Abstracts from the 6th Respiratory Efectiveness Group Summit, 18–20 March, 2021

Dec 21

Issue: 1/2021

2020 (Volume 21 | 2 Issues)

Dec 20

Issue: 1/2020

Sep 20

Issue: Special Issue 1/2020

Results from the Phase I study programme for navafenterol (AZD8871), a novel inhaled dual pharmacology bronchodilator (MABA)

2019 (Volume 20 | 1 Issues)

Dec 19

Issue: 1/2019

2018 (Volume 19 | 2 Issues)

Dec 18

Issue: Special Issue 1/2018

Abstracts from the 2018 Respiratory Effectiveness Group Summit

Dec 18

Issue: 1/2018

2017 (Volume 18 | 1 Issues)

Dec 17

Issue: 1/2017

2016 (Volume 17 | 1 Issues)

Dec 16

Issue: 1/2016

2015 (Volume 16 | 1 Issues)

Dec 15

Issue: 1/2015

2014 (Volume 15 | 1 Issues)

Dec 14

Issue: 1/2014

2013 (Volume 14 | 2 Issues)

Dec 13

Issue: 1/2013

Apr 13

Issue: Special Issue 1/2013

IPF in 2011 Key updates on guidelines and therapeutics

2012 (Volume 13 | 1 Issues)

Dec 12

Issue: 1/2012

2011 (Volume 12 | 1 Issues)

Dec 11

Issue: 1/2011

2010 (Volume 11 | 1 Issues)

Dec 10

Issue: 1/2010

2009 (Volume 10 | 1 Issues)

Dec 09

Issue: 1/2009

2008 (Volume 9 | 1 Issues)

Dec 08

Issue: 1/2008

2007 (Volume 8 | 1 Issues)

Dec 07

Issue: 1/2007

2006 (Volume 7 | 1 Issues)

Dec 06

Issue: 1/2006

2005 (Volume 6 | 1 Issues)

Dec 05

Issue: 1/2005